Patents by Inventor Tanvi Deshpande

Tanvi Deshpande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ESTER NITRATES DERIVATIVES OF AROMATIC ALDEHYDES WITH MULTIPLE PHARMALOGIC PROPERTIES TO TREAT SICKLE CELL DISEASE
    Publication number: 20210053931
    Abstract: The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.
    Type: Application
    Filed: November 3, 2020
    Publication date: February 25, 2021
    Inventors: Martin Safo, Yan Zhang, Jurgen Venitz, Richmond Danso-Danqua, Tanvi Deshpande
  • Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
    Patent number: 10858331
    Abstract: The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: December 8, 2020
    Assignee: Virginia Commonwealth University
    Inventors: Martin Safo, Yan Zhang, Jurgen Venitz, Richmond Danso-Danqua, Tanvi Deshpande
  • ESTER NITRATES DERIVATIVES OF AROMATIC ALDEHYDES WITH MULTIPLE PHARMALOGIC PROPERTIES TO TREAT SICKLE CELL DISEASE
    Publication number: 20200369638
    Abstract: The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Inventors: Martin Safo, Yan Zhang, Jurgen Venitz, Richmond Danso-Danqua, Tanvi Deshpande
  • Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
    Patent number: 10800751
    Abstract: The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: October 13, 2020
    Assignee: Virginia Commonwealth University
    Inventors: Martin Safo, Jurgen Venitz, Richmond Danso-Danquah, Tanvi Deshpande, Yan Zhang